May 6, 2008 - Delphi Medical Systems, a subsidiary of Delphi Corp., is introducing its new portable oxygen concentrator, the Central Air, which can help patients gain increased freedom and independence by providing exceptional durability in a lightweight package. Delphi also announced that it has entered an exclusive agreement with evo Medical Solutions to distribute the device in North America for millions of adults who require supplemental oxygen treatment after being diagnosed with chronic obstructive pulmonary disease (COPD). Currently, the device has 510(k) clearance from the U.S. Food and Drug Administration (FDA). Delphi's design delivers concentrated oxygen in a compact size and convenient format, and boasts the smallest footprint and package size in its class. Measuring under a foot high and weighing less than 10 pounds, the unit allows premium portability so that patients can participate in more mobile lifestyles... Delphi Medical Systems' Press Release -
